Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel

International Journal of Pharmaceutics

Volumn 483, Issue 1-2, 2015, Pages 38-48

  Li, Jing ^a,b   Yin, Tingjie ^a   Wang, Lei ^a   Yin, Lifang ^a   Zhou, Jianping ^a   Huo, Meirong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor; Drug delivery; Hyaluronic acid; Paclitaxel; Polymeric micelle; Redox sensitive

Indexed keywords

DEOXYCHOLIC ACID; GLUTATHIONE; HYALURONIC ACID; PACLITAXEL; ANTINEOPLASTIC AGENT; MICELLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CONJUGATE; CONTROLLED STUDY; CYTOPLASM; DEGRADATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; FLOW CYTOMETRY; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; OXIDATION REDUCTION REACTION; PATHOLOGY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DEOXYCHOLIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; NEOPLASMS, EXPERIMENTAL; OXIDATION-REDUCTION; PACLITAXEL; PARTICLE SIZE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 84922526873     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.02.002     Document Type: Article

References (36)

1. A. Al-Nahain, S.Y. Lee, I. In, K.D. Lee, and S.Y. Park Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted Pluronic Int. J. Pharm. 450 2013 208 217
2. A. Albini, and M.B. Sporn The tumour microenvironment as a target for chemoprevention Nat. Rev. Cancer 7 2007 139 147
3. A.A. Alexander-Bryant, W.S. Vanden Berg-Foels, and X. Wen Bioengineering strategies for designing targeted cancer therapies Adv. Cancer Res. 118 2013 1 59
4. K. Belguise, N. Kersual, F. Galtier, and D. Chalbos FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells Oncogene 24 2005 1434 1444
5. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev. 66 2014 2 25
6. L. Brulisauer, M.A. Gauthier, and J.C. Leroux Disulfide-containing parenteral delivery systems and their redox-biological fate J. Control Release 2014
7. K.Y. Choi, H. Chung, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, I.C. Kwon, and S.Y. Jeong Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 31 2010 106 114
8. K.Y. Choi, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, I.C. Kwon, K. Choi, and S.Y. Jeong PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo Biomaterials 32 2011 1880 1889
9. J.A. Cook, H.I. Pass, S.N. Iype, N. Friedman, W. DeGraff, A. Russo, and J.B. Mitchell Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue Cancer Res. 51 1991 4287 4294
10. J.E. Draffin, S. McFarlane, A. Hill, P.G. Johnston, and D.J. Waugh CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells Cancer Res. 64 2004 5702 5711
11. S. Feng, and G. Huang Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers J. Control Release 71 2001 53 69
12. C. Garofalo, G. Capuano, R. Sottile, R. Tallerico, R. Adami, E. Reverchon, E. Carbone, L. Izzo, and D. Pappalardo Different insight into amphiphilic PEG-PLA copolymers: influence of macromolecular architecture on the micelle formation and cellular uptake Biomacromolecules 15 2014 403 415
13. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598
14. K.K. Gill, S. Nazzal, and A. Kaddoumi Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation Eur. J. Pharm. Biopharm. 79 2011 276 284
15. M.C. Giuffrida, F. Dosio, F. Castelli, and M.G. Sarpietro Lipophilic prodrug of paclitaxel: interaction with a dimyristoylphosphatidylcholine monolayer Int. J. Pharm. 475 2014 624 631
16. M. Huo, Y. Zhang, J. Zhou, A. Zou, D. Yu, Y. Wu, J. Li, and H. Li Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug Int. J. Pharm. 394 2010 162 173
17. P. Kuppusamy, H. Li, G. Ilangovan, A.J. Cardounel, J.L. Zweier, K. Yamada, M.C. Krishna, and J.B. Mitchell Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels Cancer Res. 62 2002 307 312
18. C. Li, Y. Li, Y. Gao, N. Wei, X. Zhao, C. Wang, Y. Li, X. Xiu, and J. Cui Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Int. J. Pharm. 468 2014 15 25
19. J. Li, M. Huo, J. Wang, J. Zhou, J.M. Mohammad, Y. Zhang, Q. Zhu, A.Y. Waddad, and Q. Zhang Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel Biomaterials 33 2012 2310 2320
20. H. Lian, T. Zhang, J. Sun, X. Liu, G. Ren, L. Kou, Y. Zhang, X. Han, W. Ding, X. Ai, C. Wu, L. Li, Y. Wang, Y. Sun, S. Wang, and Z. He Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism Mol. Pharm. 10 2013 3447 3458
21. Y. Liu, J. Fang, Y.J. Kim, M.K. Wong, and P. Wang Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity Mol. Pharm. 11 2014 1651 1661
22. D. Maciel, P. Figueira, S. Xiao, D. Hu, X. Shi, J. Rodrigues, H. Tomas, and Y. Li Redox-responsive alginate nanogels with enhanced anticancer cytotoxicity Biomacromolecules 14 2013 3140 3146
23. L.B. Michaud, V. Valero, and G. Hortobagyi Risks and benefits of taxanes in breast and ovarian cancer Drug Saf. 23 2000 401 428
24. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
25. D.A. Ossipov Nanostructured hyaluronic acid-based materials for active delivery to cancer Expert Opin. Drug Deliv. 7 2010 681 703
26. B. Rihova, J. Strohalm, O. Hovorka, V. Subr, T. Etrych, P. Chytil, R. Pola, D. Plocova, J. Boucek, and K. Ulbrich Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences J. Control Release 127 2008 110 120
27. E.K. Rowinsky, and R.C. Donehower Paclitaxel (taxol) N. Engl. J. Med. 332 1995 1004 1014
28. E. Saadat, M. Amini, M.R. Khoshayand, R. Dinarvand, and F.A. Dorkoosh Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation Int. J. Pharm. 475 2014 163 173
29. A. Sandler, R. Gray, M.C. Perry, J. Brahmer, J.H. Schiller, A. Dowlati, R. Lilenbaum, and D.H. Johnson Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N. Engl. J. Med. 355 2006 2542 2550
30. M. Sanjoh, K. Miyata, R.J. Christie, T. Ishii, Y. Maeda, F. Pittella, S. Hiki, N. Nishiyama, and K. Kataoka Dual environment-responsive polyplex carriers for enhanced intracellular delivery of plasmid DNA Biomacromolecules 13 2012 3641 3649
31. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
32. O. Soga, C.F. van Nostrum, M. Fens, C.J. Rijcken, R.M. Schiffelers, G. Storm, and W.E. Hennink Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery J. Control Release 103 2005 341 353
33. H. Sun, F. Meng, R. Cheng, C. Deng, and Z. Zhong Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy Expert Opin. Drug Deliv. 10 2013 1109 1122
34. B. Talcott, and M.S. Moore Getting across the nuclear pore complex Trends Cell. Biol. 9 1999 312 318
35. F. Wang, Y. Chen, D. Zhang, Q. Zhang, D. Zheng, L. Hao, Y. Liu, C. Duan, L. Jia, and G. Liu Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles Int. J. Nanomed. 7 2012 325 337
36. R.B. Weiss, R.C. Donehower, P.H. Wiernik, T. Ohnuma, R.J. Gralla, D.L. Trump, J.R. Baker Jr., D.A. Van Echo, D.D. Von Hoff, and B. Leyland-Jones Hypersensitivity reactions from taxol J. Clin. Oncol. 8 1990 1263 1268